SYSTEM AND METHOD FOR DIAGNOSIS OF INFECTIOUS DISEASES

• US 20090061450A1
• Filed: 09/03/2008
• Published: 03/05/2009
• Est. Priority Date: 03/14/2006
• Status: Abandoned Application

• Current Assignee: Perkinelmer Health Sciences Incorporated (Perkinelmer Incorporated)
• Original Assignee: Micronics Inc. (Sony Group Corp.)
• Inventors: Hunter, William Samuel
• Application Number:
  US12/203,715
• Publication Number:
  US 20090061450A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: B01L 2200/0689 Sealing
• CPC Class Codes: B01L 2200/10 Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
• CPC Class Codes: B01L 2300/0867 Multiple inlets and one sample wells, e.g. mixing, dilution
• CPC Class Codes: B01L 2300/087 Multiple sequential chambers
• CPC Class Codes: B01L 2300/1827 using resistive heater
• CPC Class Codes: B01L 2400/0475 specific mechanical means and fluid pressure
• CPC Class Codes: B01L 2400/0622 distribution valves, valves having multiple inlets and/or outlets, e.g. metering valves, multi-way valves
• CPC Class Codes: B01L 3/502715 characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
• CPC Class Codes: B01L 3/5029 using swabs
• CPC Class Codes: B01L 7/52 with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples amplification or hybridisation processes per se C12Q1/68; controlling sequential reactions for synthesis B01J19/0046

Abstract

A biosafe apparatus is disclosed for assay and diagnosis of respiratory pathogens comprising a nasal sampling device, a single entry, disposable microfluidic cartridge for target nucleic acid amplification, and an instrument with on-board assay control platform and target detection means.

Claims

1. A biosafe system for assaying a target nucleic acid in a biosample, the system comprising:

a) A two-piece sample carrier comprising a swab for collecting a sample to be tested, said swab with capture end and extended neck topped by a threaded cap with locking means, and a body with compartment for accepting said swab, and further comprising a threaded upper lip and lower tubular nose with axial orifice, said orifice with inner seal;

b) A disposable microfluidic cartridge with external surfaces, with internal works, and with docking means for receiving said two-piece sample carrier, the microfluidic cartridge further comprising a bridging manifold with first fluidic channel in fluidic connection with a sample receiving receptacle, a means for sealingly accepting the tubular nose of said sample carrier in said sample receiving receptacle, a means for fluidically joining said first fluidic channel to said sample carrier, valve means for introducing and withdrawing lysis reagent to and from said compartment, a means for extracting a target nucleic acid from a sample lysate, a means for eluting a target nucleic acid, an amplification chamber and stirrer means for amplifying a nucleic acid in a sample eluate, a lightpath through said chamber for detecting an amplification product by optical detection means; and

,

c) A control platform instrument with microprocessing means for sealedly engaging and controlling said internal works of said microfluidic cartridge, said means for sealingly engaging and controlling comprising at least one ported external hydraulic interface on said microfluidic cartridge, and detection means for reading and displaying an assay result; and

further,

d) Wherein said means for sealingly accepting the tubular nose of said sample carrier in said sample receiving receptacle, said means for fluidically joining said first fluidic channel to said sample carrier, and said means for sealedly engaging and controlling said internal works are configured to isolate said nasal swab, internal works of said microfluidic cartridge, external surfaces, and instrument, from forward and reverse contamination.

2. A biosafe system of claim 1 wherein said means for sealingly accepting the tubular nose of said sample carrier in said sample receiving receptacle comprises a compression seal formed between said tubular nose with orifice and said sample receiving receptacle in said bridging manifold, said compression seal further comprising a snap-lock mechanism formed of a mating undercut locking ring in said sample receiving receptacle and an oversized barbed lip on said tubular nose with axial orifice, such that insertion of the barbed lip through said locking ring irreversibly secures said compression seal.

3. A biosafe system of claim 1 wherein said means for fluidically joining said first fluidic channel to said sample carrier comprises a snap-lock mechanism formed of a mating female locking ring in said sample receiving receptacle and an oversized barbed lip on said tubular nose, and further comprises a sharp mounted in said sample receiving receptacle of said bridging manifold and extending into said axial orifice of said tubular nose, whereby said sharp pierces said inner seal and forms a patent fluid path between said first fluidic channel of said sample receiving manifold and said sample body compartment containing said nasal swab as said sample carrier is pressed into said sample receiving receptacle of said bridging manifold, said press fit assembly further aided by docking means.

4. A biosafe system of claim 1, wherein said stirring means comprises a stirring motor with magnet on said control platform instrument and a stir bar with arms with ferromagnetic elements at the tips of said arms in said amplification chamber.

5. A biosafe system of claim 4, wherein said stir bar is transparent except at the tips of said arms.

6. A biosafe system of claim 1, wherein said optical detection means comprises an LED/photodiode pair straddling said optical window over said amplification chamber.

7. A biosafe system of claim 6, wherein said optical detection means further comprises an interference filter.

8. A biosafe system of claim 1, further comprising a resistive heating element contactingly disposed on said amplification chamber.

9. A biosafe system of claim 1, wherein said resistive heating element is a transparent ITO heating element.

19. The biosafe system of claim 1, wherein the microfluidics cartridge assembly and control platform instrument combination is portable.

10. A method for assaying a biosample for a target nucleic acid, the method comprising:

a) Collecting a sample with a swab and threadedly sealing said swab in a sample compartment in a sample carrier;

said sample carrier further with tubular nose with central orifice, said orifice with inner seal;

then,

b) Sealingly assembling said sample carrier into a sample receiving receptacle of a microfluidic cartridge, said sample receiving receptacle with piercing means, thereby piercing said inner seal and fluidically joining said sample compartment with a first fluidic channel of said microfluidic cartridge, thereby forming a microfluidics cartridge assembly; and

thereafter,

c) Engaging said microfluidics cartridge assembly in a control platform instrument; and

,

d) Sealedly introducing and withdrawing a lysis reagent to and from said sample compartment via said first fluidic channel, thereby forming a sample lysate; and

aspirating said lysate into an isolation chamber on said microfluidics cartridge assembly; and

therein,

e) Sealedly extracting a target nucleic acid from said sample lysate nucleic acid onto a solid phase matrix, thereby forming a solid phase retentate; and

,

f) Sealedly eluting the target nucleic acid from said solid phase matrix, thereby forming an eluate; and

further,

g) Sealedly amplifying said target nucleic acid with amplification reagents;

before,

h) Sealedly detecting amplification products by optical detection means;

i) And further having controlled said steps of the assay by activating electrical and hydraulic control interfaces of said control instrument platform;

before finally,

j) Disposing said microfluidics cartridge assembly.

11. The method of claim 10 wherein said amplification step comprises a LAMP protocol.

12. The method of claim 10, wherein said optical detection means comprises a step for hybridizing a probe with fluorophore.

13. The method of claim 10, wherein said optical detection means comprises a step for turbidometry.

14. The method of claim 10 wherein the nucleic acid target is a nucleic acid of a respiratory pathogen.

15. The method of claim 14 further comprising a step for reverse transcriptase mediated synthesis of cDNA from RNA of a respiratory pathogen.

16. The method of claim 10 wherein the nucleic acid target is a host genomic DNA.

17. The method of claim 10 further comprising a control reaction run side-by-side with the bioassay.

18. The method of claim 10 wherein said amplification reagents are provided on-cartridge as dehydrated reagents.

20. The steps, features, integers, compositions and/or compounds disclosed herein or indicated in the specification of this application individually or collectively, and any and all combinations of two or more of said steps or features.